Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Pipe

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Blood Cells, Molecules & Diseases|June 18, 2002
Expression of factor VIII in recombinant and transgenic systemsSerguei Soukharev, David Hammond, Natalya M Ananyeva, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 4, 2022
Association of factor expression levels with annual bleeding rate in people with haemophilia BTom Burke, Anum Shaikh, Talaha M Ali, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 30, 2023
A global comparative field study to evaluate the factor VIII activity of efanesoctocog alfa by one-stage clotting and chromogenic substrate assays at clinical haemostasis laboratoriesSteven Pipe, Ali Sadeghi-Khomami, Barbara A Konkle, et al.
Journal of Thrombosis and Haemostasis : JTH|January 19, 2021
Core data set on safety, efficacy, and durability of hemophilia gene therapy for a global registry: Communication from the SSC of the ISTHBarbara Konkle, Glen Pierce, Donna Coffin, et al.
Journal of Thrombosis and Haemostasis : JTH|March 16, 2025
Corticosteroid use to mitigate transaminitis-associated decline in FVIII levels following valoctocogene roxaparvovec gene therapy: clinical practice guidanceBarbara A Konkle, Flora Peyvandi, Graham R Foster, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 19, 2020
Real-world data of immune tolerance induction using recombinant factor VIII Fc fusion protein in patients with severe haemophilia A with inhibitors at high risk for immune tolerance induction failure: A follow-up retrospective analysisManuel Carcao, Amy Shapiro, Nina Hwang, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 25, 2025
The WFH Guidelines for the Management of Haemophilia: AAV Gene Therapy, 2025Glenn F Pierce, Margareth C Ozelo, Johnny Mahlangu, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Blood Cells, Molecules & Diseases|June 18, 2002
Expression of factor VIII in recombinant and transgenic systemsSerguei Soukharev, David Hammond, Natalya M Ananyeva, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 4, 2022
Association of factor expression levels with annual bleeding rate in people with haemophilia BTom Burke, Anum Shaikh, Talaha M Ali, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 30, 2023
A global comparative field study to evaluate the factor VIII activity of efanesoctocog alfa by one-stage clotting and chromogenic substrate assays at clinical haemostasis laboratoriesSteven Pipe, Ali Sadeghi-Khomami, Barbara A Konkle, et al.
Journal of Thrombosis and Haemostasis : JTH|January 19, 2021
Core data set on safety, efficacy, and durability of hemophilia gene therapy for a global registry: Communication from the SSC of the ISTHBarbara Konkle, Glen Pierce, Donna Coffin, et al.
Journal of Thrombosis and Haemostasis : JTH|March 16, 2025
Corticosteroid use to mitigate transaminitis-associated decline in FVIII levels following valoctocogene roxaparvovec gene therapy: clinical practice guidanceBarbara A Konkle, Flora Peyvandi, Graham R Foster, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 19, 2020
Real-world data of immune tolerance induction using recombinant factor VIII Fc fusion protein in patients with severe haemophilia A with inhibitors at high risk for immune tolerance induction failure: A follow-up retrospective analysisManuel Carcao, Amy Shapiro, Nina Hwang, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 25, 2025
The WFH Guidelines for the Management of Haemophilia: AAV Gene Therapy, 2025Glenn F Pierce, Margareth C Ozelo, Johnny Mahlangu, et al.
Pageof 3